PAVmed Inc. (PAVM)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 400K 800K 1.2M Q3 '21: 200K Q4 '21: 300K Q1 '22: 189K Q2 '22: 0 Q3 '22: 76K Q4 '22: 112K Q1 '23: 446K Q2 '23: 166K Q3 '23: 791K Q4 '23: 1M Q1 '24: 1M Q2 '24: 979K Q3 '24: 996K Q4 '24: 10K Q1 '25: 8K Q2 '25: 6K Q3 '25: 5K Q4 '25: 52K Q1 '26: 22K Q2 '26: 33K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

-210K -140K -70K 0 70K 140K 210K Q3 '21: 56K Q4 '21: -141K Q1 '22: -180K Q2 '22: 0 Q3 '21 Q4 '21 Q1 '22 Q2 '22

Operating Income Quarterly

-27M -18M -9M 0 9M 18M 27M Q3 '16: -1.9M Q4 '16: -1.7M Q1 '17: -2.2M Q2 '17: -2M Q3 '17: -2M Q4 '17: -1.9M Q1 '18: -1.9M Q2 '18: -2.7M Q3 '18: -2.6M Q4 '18: -3.3M Q1 '19: -3.1M Q2 '19: -3.3M Q3 '19: -3.2M Q4 '19: -4.6M Q1 '20: -5.3M Q2 '20: -5M Q3 '20: -5.5M Q4 '20: -7.6M Q1 '21: -8.1M Q2 '21: -13M Q3 '21: -13.7M Q4 '21: -19.7M Q1 '22: -19.6M Q2 '22: -23.5M Q3 '22: -23.4M Q4 '22: -24.6M Q1 '23: -20.4M Q2 '23: -16.5M Q3 '23: -15.5M Q4 '23: -16.4M Q1 '24: -14M Q2 '24: -13.7M Q3 '24: -11.6M Q4 '24: -5.2M Q1 '25: -5.4M Q2 '25: -4.7M Q3 '25: -4.8M Q4 '25: -6.8M Q1 '26: -8M Q2 '26: -7M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-50M -25M 0 25M 50M 75M Q3 '16: -1.9M Q4 '16: -1.7M Q1 '17: -4.3M Q2 '17: -989.7K Q3 '17: -5.1M Q4 '17: 309.7K Q1 '18: -2.8M Q2 '18: -5.1M Q3 '18: -3.2M Q4 '18: -6.8M Q1 '19: -3.5M Q2 '19: -3.6M Q3 '19: -3.1M Q4 '19: -6.2M Q1 '20: -14.5M Q2 '20: -5.6M Q3 '20: -5.5M Q4 '20: -8.7M Q1 '21: -9.4M Q2 '21: -11.5M Q3 '21: -12.2M Q4 '21: -17.2M Q1 '22: -16.9M Q2 '22: -25.5M Q3 '22: -26.1M Q4 '22: -20.5M Q1 '23: -17.9M Q2 '23: -14.5M Q3 '23: -17.7M Q4 '23: -14M Q1 '24: -15.2M Q2 '24: -10.8M Q3 '24: 64.4M Q4 '24: 1.4M Q1 '25: 19M Q2 '25: -11.9M Q3 '25: -5.4M Q4 '25: -1.3M Q1 '26: -60K Q2 '26: -5.4M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 700K 1.4M 2.1M Q3 '21: 144K Q4 '21: 441K Q1 '22: 369K Q2 '22: 0 Q3 '22: 1.6M Q4 '22: 1.6M Q1 '23: 1.3M Q2 '23: 1.7M Q3 '23: 1.8M Q4 '23: 1.6M Q1 '24: 1.7M Q2 '24: 1.7M Q3 '24: 1.4M Q4 '24: 48K Q1 '25: 36K Q2 '25: 41K Q3 '25: 55K Q4 '25: 85K Q1 '26: 97K Q2 '26: 122K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-24M -16M -8M 0 8M 16M 24M Q3 '16: -1.2M Q4 '16: -1.2M Q1 '17: -1.8M Q2 '17: -823.6K Q3 '17: -2.4M Q4 '17: -1.6M Q1 '18: -2.2M Q2 '18: -1.7M Q3 '18: -1.9M Q4 '18: -3M Q1 '19: -3.9M Q2 '19: -2.5M Q3 '19: -2.9M Q4 '19: -4.1M Q1 '20: -3.8M Q2 '20: -5.6M Q3 '20: -5.8M Q4 '20: -6.7M Q1 '21: -9.2M Q2 '21: -6.6M Q3 '21: -8M Q4 '21: -16.8M Q1 '22: -12.3M Q2 '22: -22.6M Q3 '22: -19.3M Q4 '22: -16.8M Q1 '23: -16.4M Q2 '23: -12.7M Q3 '23: -11.1M Q4 '23: -11.9M Q1 '24: -13.1M Q2 '24: -11.7M Q3 '24: -8.9M Q4 '24: 94K Q1 '25: -1.6M Q2 '25: -1.2M Q3 '25: -896K Q4 '25: -1.6M Q1 '26: -2.6M Q2 '26: -2.7M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-24M -16M -8M 0 8M 16M 24M Q1 '16: -531.2K Q2 '16: -1.5M Q3 '16: -1.2M Q4 '16: -1.2M Q1 '17: -1.8M Q2 '17: -823.6K Q3 '17: -2.4M Q4 '17: -1.6M Q4 '18: -3M Q1 '19: -3.9M Q2 '19: -2.5M Q3 '19: -2.9M Q4 '19: -4.1M Q1 '20: -3.8M Q2 '20: -5.6M Q3 '20: -5.8M Q4 '20: -6.7M Q1 '21: -9.2M Q2 '21: -6.7M Q3 '21: -8.1M Q4 '21: -18.1M Q1 '22: -12.8M Q2 '22: -22.9M Q3 '22: -19.7M Q4 '22: -17.1M Q1 '23: -16.4M Q2 '23: -12.7M Q3 '23: -11.1M Q4 '23: -12.1M Q1 '24: -13.2M Q2 '24: -11.7M Q3 '24: -8.9M Q4 '24: 90K Q1 '25: -1.6M Q2 '25: -1.2M Q3 '25: -899K Q4 '25: -1.6M Q1 '26: -2.6M Q2 '26: -2.7M Q4 '16 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 35M 70M 105M Q1 '15: 10.9M Q2 '15: 10.9M Q3 '15: 11.1M Q1 '16: 12.2M Q2 '16: 13M Q3 '16: 13.3M Q1 '21: 74M Q2 '21: 82.2M Q3 '21: 83.3M Q1 '22: 86.3M Q2 '22: 87M Q3 '22: 89.8M Q1 '23: 6.5M Q2 '23: 7M Q3 '23: 7.5M Q1 '24: 8.7M Q2 '24: 9.2M Q3 '24: 44.5M Q1 '25: 1.7M Q2 '25: 602.8K Q3 '25: 21.6M Q1 '26: 1.6M Q2 '26: 6.3M Q2 '15 Q2 '16 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-27.00 -18.00 -9.00 0.00 9.00 18.00 27.00 Q4 '15: -0.15 Q1 '16: -0.20 Q2 '16: -0.27 Q3 '16: -0.36 Q2 '17: -0.67 Q3 '17: -0.91 Q4 '17: -0.71 Q1 '18: -0.56 Q2 '18: -0.74 Q3 '18: -0.48 Q4 '18: -0.83 Q1 '19: -0.79 Q2 '19: -0.66 Q3 '19: -0.64 Q4 '19: -0.55 Q1 '20: -0.75 Q2 '20: -0.74 Q3 '20: -0.75 Q4 '20: -0.72 Q1 '21: -0.52 Q2 '21: -0.54 Q3 '21: -0.58 Q4 '21: -0.66 Q1 '22: -0.73 Q2 '22: -0.88 Q3 '22: -1.02 Q4 '22: -15.03 Q1 '23: -17.61 Q2 '23: -19.42 Q3 '23: -21.51 Q4 '23: -9.19 Q1 '24: -9.03 Q2 '24: -8.12 Q3 '24: -4.30 Q4 '24: 11.74 Q1 '25: 24.46 Q2 '25: 3.57 Q3 '25: 1.84 Q4 '25: -5.63 Q3 '16 Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.